Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortés(International Breast Cancer Study Group), David W. Cescon(Princess Margaret Cancer Centre), Hope S. Rugo(University of California, San Francisco), Zbigniew Nowecki(The Maria Sklodowska-Curie National Research Institute of Oncology), Seock‐Ah Im(Seoul National University Hospital), Mastura Md Yusof(Hospital Kuala Lumpur), Carlos Gallardo(Fundación Arturo López Pérez), Oleg Lipatov(Republican Oncological Clinical Dispensary), Carlos H. Barrios(Hospital São Lucas da PUCRS), Esther Holgado(Vall d'Hebron Institute of Oncology), Hiroji Iwata(Aichi Cancer Center), Norikazu Masuda(Osaka National Hospital), Marco Torregroza Otero, Erhan Gökmen(Ege University), Sherene Loi(Peter MacCallum Cancer Centre), Zifang Guo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jing Zhao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gursel Aktan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Vassiliki Karantza(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Schmid(Queen Mary University of London), F. Vidal Luis, Gomez Abuin Gonzalo, Diego Kaen, Kowalwszyn Ruben, Molina Matias, Varela Mirta, Sally Baron-Hay, Begbie Stephen, Clingan Philip, Loi Sherene(Peter MacCallum Cancer Centre), Sabanathan Dhanusha, Andrea Gombos, Donatienne Taylor, Carlos Barrios(Hospital São Lucas da PUCRS), Leandro Brust, Costa Fabiano, de Freitas Junior Ruffo, Roberto Hegg, Lacerda Domicio Carvalho, Lissa Fernando Cezar Toniazzi, Rocha Roberto Odebrecht, Scalabrini Neto Antonio Orlando, Silva Felipe, Cescon David(Princess Margaret Cancer Centre), Danielle Charpentier, Ferrario Cristiano, Xinni Song, Yu Joanne(Hospital Kuala Lumpur), Alejandro Acevedo, Gallardo Carlos(Fundación Arturo López Pérez), Salas Claudio, Sanchez Cesar, Eduardo Yañez, Gomez Diaz Alvaro, Sanchez Jesus, Holeckova Petra, Kral Zdenek, Bohuslav Melichar, Katarína Petráková, Prausova Jana, Vesna Glavicic, Jakobsen Erik, Jensen Jeanette, Søren Linnet, Tamás Lörincz, Bonnefoi Herve, Isabelle Desmoulins, Goncalves Anthony, Hardy-Bessard Anne-Claire, Luís Teixeira, Blohmer Jens-Uwe, Fasching Peter(Queen Mary University of London), Dirk Forstmeyer, Nadia Harbeck, Huober Jens, Kaczerowsky Flores de Sousa Anna, Kurbacher Christian, Sibylle Loibl, Lueftner Diana, Park-Simon Tjoung-Won, Schumann Raquel Von, Pauline Wimberger, Chow Louis, Kwong Ava, Ngan Kai Cheong Roger, Peter Arkosy(Queen Mary University of London), Tibor Csőszi, Zsuzsanna Kahán, Landherr László, Mahr Karoly, Gábor Rubovszky, Crown John, Kelly Catherine, O'Reilly Seamus, Saverio Cinieri, DAlessio Antonietta, Ricevuto Enrico, Tomoyuki Aruga, Takaaki Fujii, Inoue Kenichi, Takashi Ishikawa, Ito Yoshinori, Tsutomu Iwasa, Iwata Hiroji(Aichi Cancer Center), Yoshimasa Kosaka, Matsumoto Koji, Yasuo Miyoshi, Hirofumi Mukai, Seigo Nakamura, Naoki Niikura, Ohtani Shoichiro, Osaki Akihiko, Yasuaki Sagara, Suzuki Eiji, Masato Takahashi, Yuko Tanabe, Kenji Tamura, Koichiro Tsugawa, Junichiro Watanabe, Yamamoto Naohito, Yutaka Yamamoto, Teruo Yamauchi, Bustam Anita, M.Y. Mastura(Hospital Kuala Lumpur), Gomez Villanueva Angel, Juarez Ramiro Alejandro, Martinez Rodriguez Jorge, Morales-Vasquez Flavia, Reyes Contreras Jessica, Beelen Karin, Tjan-Heijnen Vivianne, Porter David(Princess Margaret Cancer Centre), Ewa Chmielowska, Nowakowska-Zajdel Ewa, Nowecki Zbigniew(The Maria Sklodowska-Curie National Research Institute of Oncology), Radecka Barbara, Joanna Streb, Szczylik Cezary, R. Tarnawski, Zurawski Bogdan, Arkhipov Alexander, Natalia Fadeeva, Oleg Lipatov(Republican Oncological Clinical Dispensary), Meshcheryakov Andrey, Moiseyenko Vladimir, Mukhametshina Guzel, Ahn Jin Hee, Im Seock-Ah(Seoul National University Hospital), Lee Keun Seok, Park Kwong Hwa, Park Yeon Hee, Bermejo de las Heras Begona, Cortes Javier(Vall d'Hebron Institute of Oncology), Cruz Jurado Josefina, de la Cruz Merino Luis, Garcia Saenz Jose, Maria Gion, Esther Holgado(Vall d'Hebron Institute of Oncology), Zamora Adelantado Esther(Vall d'Hebron Institute of Oncology), Chien-Ting Liu, Mei-Ching Liu, Chiun‐Sheng Huang, Tsao Chao-Jung, Ling-Ming Tseng, Çağatay Arslan, Basaran Gul, İrfan Çiçin, Erhan Gokmen(Ege University), Gunduz Seyda, Molinas Mandel Nil, Özgüroğlu Mustafa, Ozyilkan Ozgur, Sinan Yavuz, C. R. Williams Steve, Graham Janine, MacPherson Iain, Schmid Peter(Queen Mary University of London), Turner Nicholas, Tuthill Mark, Twelves Christopher, W Duncan, Hryhoriy Adamchuk, Oleksandr Berzoy, Bondarenko Igor, Kolesnik Oleksii, O. Kolesnik, Komisarenko Hanna, Kryzhanivska Anna, Leshchenko Iurii, Nasonova Alla(Fundación Arturo López Pérez), Otchenash Natalya, Ponomarova Olga(Vall d'Hebron Institute of Oncology), Rusyn Andrii, Sergii Shevnya, Yaroslav Shparyk, Dmytro Trukhin, Grygorii Ursol, Vynnychenko Ihor, Sibel Blau, Madhu Chaudhry, Michael Chung, C. Patrick, C. Scott, Jennifer R. Diamond, Gogineni Keerthi, Hargis Jeffrey, Hoskins Kent, Irvin William, Randa Loutfi, Lu Janice, Mena Raul, Moore Susan, Rita Nanda, Ira Oliff, Omene Coral, Panella Timothy, Panwalkar Amit, Brian J. Patson, Hope Rugo(University of California, San Francisco), Irina Rybalova, Schleider Michael, Siegel Robert, Simon Michael, Stampleman Laura, Sumrall Bradley, Tsai Michaela, Frances Valdes-Albini
Cited by 1,786Open Access
Abstract
Related Papers
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al.|American Journal of Clinical Oncology|1982|11.6k